1. Bass, R., Beck, F., Merker, H.-J., Neubert, D., and Randhahn, B. 1970. Metabolic Pathways in Mammalian Embryos During Organogenesis and Its Modification by Drugs. Freie Universität, Berlin.
2. Beaudoin, A. R. 1985. Validity of in vitro methods in teratogenicity testing, in: New Approaches in Toxicity Testing and Application in Human Risk Assessment, A. P. Li, ed. Raven Press, New York, pp. 203–212.
3. Bechter, R., and Schmid, B. P. 1987. Teratogenicity in vitro: a comparative study of four antimycotic drugs using the whole-embryo culture system. Toxicol. In Vitro 1:11–15.
4. Bechter, R., Schmid, B., and Mayer, F. K. 1986. Teratogenic potential of antimycotic drugs evaluated in the whole-embryo culture system. Food Chem. Toxicol. 24:641–642.
5. Best, J. B., and Morita, M. 1982. Planarians as a model system for in vitro teratogenesis studies. Teratog. Carcinog. Mutag. 2:277–291.